Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04179721 · ClinicalTrials.gov registry record · NA

Reducing Behavioral and Psychological Symptoms of Dementia: Hospital Caregivers (Aim 2)

A NA study of Alzheimer's Disease and Related Dementias, sponsored by Northwell Health.

Completed
Registry status
NA
Development phase
54
Enrollment target
2
Study locations

NCT04179721: Completed NA study of Alzheimer's Disease and Related Dementias, sponsored by Northwell Health.

NCT04179721 is a NA study of Alzheimer's Disease and Related Dementias that has completed, run by Northwell Health. The registered enrollment target is 54 participants, below the 1,629-participant average among 5 other Alzheimer's Disease and Related Dementias trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04179721, a NA study of Alzheimer's Disease and Related Dementias, has completed, sponsored by Northwell Health.

COMPLETED
Registry status
NA
Development phase
54 participants
Enrollment target
2
Study locations

Study Summary

Persons with Alzheimer's Disease and Related Dementias (ADRD) account for 3.2 million hospital admissions per year and have over three times more hospitalizations than those without cognitive impairment, yet hospital caregivers (HCGs) are ill-prepared to manage patients with ADRD with less than 5% reporting mandatory dementia care training. Three-quarters of hospitalized persons with ADRD display Behavioral and Psychological Symptoms of Dementia (BPSD) associated with functional and cognitive decline, increased resource consumption, institutionalization, premature death, and caregiver burden. The overall objective is to test the preliminary efficacy of an innovative model of care, PES-4-BPSD, for reducing BPSD by empowering Patient Engagement Specialists (PES) to deliver dementia care for acutely-ill patients with ADRD. Traditionally, mental health assistants with training in crisis-prevention techniques provide care to psychiatric patients. On the intervention unit, these mental health assistants, as PES, purposefully engage patients with BPSD. In the pilot study, investigators found patients with cognitive impairment admitted to the PES unit were significantly less likely to require constant observation, chemical and physical restraints, suggesting improved management of BPSD. The central hypothesis is that PES-4-BPSD will improve the ability of PES to create an "enabling" milieu that addresses factors leading to BPSD and improves the experience of hospital caregivers. Guided by a social-ecological framework, PES-4-BPSD incorporates dementia education and training, environmental modifications-cohorting, increased staffing-PES, and staff support. The investigators' multidisciplinary research team is well-positioned to accomplish the following: Aim 1) Determine the preliminary efficacy of PES-4-BPSD for reducing BPSD during hospitalization (please refer to NCT# 04481568 for more details on this aim), and Aim 2) Evaluate whether dementia care training improves the pe

Primary Outcome

The Approaches to Dementia Questionnaire (ADQ) is a 19-item scale designed to evaluate staff attitudes to people with dementia and providing dementia care. A five-point Likert Scale (1-5) is used for each item. The ADQ total score ranges from 19-95 with higher scores indicating a more positive attitude. The ADQ will be completed by Patient Engagement Specialists and Nurse Assistants at baseline (enrollment) and 3 months from enrollment. The average ADQ score at baseline and at 3 months was calcu

Interventions

  • BEHAVIORAL PES-4-BPSD Model
  • BEHAVIORAL The attention control condition

Study Locations (2)

New York

  • Long Island Jewish Medical Center - Glen Oaks
  • North Shore University Hospital - Manhasset

Trial Details

FieldValue
Enrollment Target 54 participants
Start Date 2019-10-22
Est. Completion 2021-05-18
Phase NA
Northwell Health

370 total trials

What the finished NCT04179721 record still lists

NCT04179721 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 1,629-participant average among 5 other Alzheimer's Disease and Related Dementias trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Alzheimer's Disease and Related Dementias appearing as the primary indexed condition, and to 2 interventions - of which PES-4-BPSD Model is the first listed.

NCT04179721 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT04179721 about?

NCT04179721 is a clinical study titled "Reducing Behavioral and Psychological Symptoms of Dementia: Hospital Caregivers (Aim 2)". Persons with Alzheimer's Disease and Related Dementias (ADRD) account for 3.2 million hospital admissions per year and have over three times more hospitalizations than those without cognitive impairment, yet hospital caregivers (HCGs) are ill-prepared to manage patients with ADRD with less than 5% r...

What is the current status of trial NCT04179721?

This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2019-10-22. Estimated completion is 2021-05-18.

What conditions does trial NCT04179721 study?

This clinical trial studies the following conditions: Alzheimer's Disease and Related Dementias.

What interventions are being tested in trial NCT04179721?

The interventions under investigation include: PES-4-BPSD Model (BEHAVIORAL), The attention control condition (BEHAVIORAL).

Who is sponsoring clinical trial NCT04179721?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04179721 being conducted?

This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimer's Disease and Related Dementias

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01269853 · 54 participants · Phase 1

    Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA

  • NCT02390752 · 54 participants · Phase 1

    Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...

  • NCT02991248 · 54 participants · NA

    Improve Dynamic Lateral Balance of Humans With SCI

  • NCT02993900 · 54 participants · NA

    Image-Guided Gynecologic Brachytherapy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04179721, the US trial registry maintained by the National Library of Medicine. NCT04179721 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.